Fortis Healthcare Limited (BOM:532843)
India · Delayed Price · Currency is INR 916.90
-11.30 (-1.22%)
At close: Feb 13, 2026
Fortis Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 87,704 | 77,828 | 68,929 | 62,976 | 57,176 | 40,301 |
Other Revenue | 33.65 | 33.65 | 44.73 | - | - | - |
Revenue | 87,737 | 77,861 | 68,974 | 62,976 | 57,176 | 40,301 |
Revenue Growth (YoY) | 16.03% | 12.88% | 9.52% | 10.14% | 41.87% | -13.00% |
Cost of Revenue | 37,126 | 32,005 | 29,239 | 39,894 | 24,923 | 19,582 |
Gross Profit | 50,612 | 45,857 | 39,735 | 23,082 | 32,253 | 20,719 |
Selling, General & Admin | 4,152 | 4,152 | 3,417 | 3,084 | 2,265 | 1,321 |
Other Operating Expenses | 26,656 | 25,902 | 23,699 | 8,997 | 19,340 | 15,308 |
Operating Expenses | 35,105 | 33,911 | 30,541 | 15,239 | 24,650 | 19,536 |
Operating Income | 15,507 | 11,946 | 9,194 | 7,844 | 7,603 | 1,183 |
Interest Expense | -2,554 | -1,421 | -936.01 | -985.87 | -1,194 | -1,408 |
Interest & Investment Income | 598.35 | 598.35 | 298.94 | 238.29 | 215.48 | 420.13 |
Earnings From Equity Investments | 147.73 | 115.23 | 95.1 | 218.4 | 241.47 | 475.59 |
Currency Exchange Gain (Loss) | 7.54 | 7.54 | 3.64 | 154.6 | 15.9 | -121 |
Other Non Operating Income (Expenses) | -328.38 | -319.68 | -272.98 | -178.43 | -188.94 | -146.17 |
EBT Excluding Unusual Items | 13,378 | 10,927 | 8,383 | 7,291 | 6,693 | 403.72 |
Impairment of Goodwill | - | - | - | - | -123.11 | - |
Gain (Loss) on Sale of Investments | 2.54 | 2.54 | 3.81 | 7.4 | - | - |
Gain (Loss) on Sale of Assets | 34.87 | 34.87 | 35.02 | 169.08 | 35.22 | 17.69 |
Legal Settlements | -0.35 | -0.35 | -1.9 | -4.35 | -0.53 | -0.57 |
Other Unusual Items | -633.16 | -893.36 | 160.17 | 736.1 | 3,273 | 12.12 |
Pretax Income | 12,782 | 10,070 | 8,580 | 8,199 | 9,878 | 432.95 |
Income Tax Expense | 2,972 | 1,977 | 2,127 | 1,869 | 1,978 | 994.64 |
Earnings From Continuing Operations | 9,810 | 8,094 | 6,452 | 6,330 | 7,899 | -561.69 |
Net Income to Company | 9,810 | 8,094 | 6,452 | 6,330 | 7,899 | -561.69 |
Minority Interest in Earnings | -211.99 | -351.69 | -463.44 | -442.5 | -2,348 | -535.93 |
Net Income | 9,598 | 7,742 | 5,989 | 5,887 | 5,551 | -1,098 |
Net Income to Common | 9,598 | 7,742 | 5,989 | 5,887 | 5,551 | -1,098 |
Net Income Growth | 24.81% | 29.28% | 1.72% | 6.05% | - | - |
Shares Outstanding (Basic) | 755 | 755 | 755 | 755 | 755 | 755 |
Shares Outstanding (Diluted) | 755 | 755 | 755 | 755 | 755 | 755 |
Shares Change (YoY) | -0.07% | - | - | - | - | - |
EPS (Basic) | 12.71 | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 |
EPS (Diluted) | 12.71 | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 |
EPS Growth | 24.92% | 29.32% | 1.69% | 6.10% | - | - |
Free Cash Flow | - | 5,770 | 1,576 | 3,750 | 6,499 | 2,670 |
Free Cash Flow Per Share | - | 7.64 | 2.09 | 4.97 | 8.61 | 3.54 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | - | - |
Gross Margin | 57.68% | 58.89% | 57.61% | 36.65% | 56.41% | 51.41% |
Operating Margin | 17.67% | 15.34% | 13.33% | 12.46% | 13.30% | 2.94% |
Profit Margin | 10.94% | 9.94% | 8.68% | 9.35% | 9.71% | -2.72% |
Free Cash Flow Margin | - | 7.41% | 2.28% | 5.96% | 11.37% | 6.63% |
EBITDA | 18,837 | 14,996 | 11,870 | 10,369 | 9,956 | 3,470 |
EBITDA Margin | 21.47% | 19.26% | 17.21% | 16.46% | 17.41% | 8.61% |
D&A For EBITDA | 3,330 | 3,050 | 2,676 | 2,525 | 2,353 | 2,288 |
EBIT | 15,507 | 11,946 | 9,194 | 7,844 | 7,603 | 1,183 |
EBIT Margin | 17.67% | 15.34% | 13.33% | 12.46% | 13.30% | 2.94% |
Effective Tax Rate | 23.25% | 19.63% | 24.80% | 22.80% | 20.03% | 229.73% |
Revenue as Reported | 88,364 | 78,497 | 69,312 | 63,594 | 57,449 | 40,767 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.